Molecular biology cellular biology and genetics print books and ebooks | Elsevier

Cryo-EM Methods and Management

1st Edition
June 1, 2026
Edward T. Eng + 2 more
English
Paperback
9 7 8 0 4 4 3 3 3 8 2 5 0
eBook
9 7 8 0 4 4 3 3 3 8 2 6 7

Cryo-EM Methods and Management provides a detailed introduction to the latest advances of cryo-EM, from technical innovations to the logistical challenges of maintaining a modern cryo-EM facility. The book consists of four parts, beginning with an overview of cryo-EM. It then moves on to discuss Cryo-EM workflows, with chapters focusing on sample handling and preparation, data collection and hardware, and data procession and visualization. The third part centers on aspects of cryo-EM infrastructure and community building, considering facility set-up and management, monitoring facility performance, instrumentation monitoring , data sharing and standards, and training and development standards. The book then closes with a section looking towards future prospects for cryo-EM. This is an ideal reference for cryo-EM facility and lab managers, providing guidance to the often-overlooked aspect of facility building and management. Additionally researchers working with cryo-EM across molecular biology, structural biology, cell biology and biochemistry will benefit from this book.

Cell Death Part C

1st Edition
Volume 207
June 1, 2026
English
Hardback
9 7 8 0 4 4 3 4 2 8 6 9 2
eBook
9 7 8 0 4 4 3 4 2 8 7 0 8

Gene Therapy in Neurodegenerative Disorders

1st Edition
June 1, 2026
Vahid Mansouri + 1 more
English
Paperback
9 7 8 0 4 4 3 4 0 4 6 7 2
eBook
9 7 8 0 4 4 3 4 0 4 6 8 9

Gene Therapy in Neurodegenerative Disorders: From Bench to Bedside offers a comprehensive review of gene therapy modalities and their applications in treating neurodegenerative disorders. This book is designed to provide researchers, clinicians, and students with an in-depth understanding of the principles, advancements, and challenges in the field of gene therapy. The initial chapters focus on the fundamentals of gene therapy strategies, including gene delivery methods and CNS-targeted gene delivery. Subsequent chapters delve into specific neurodegenerative disorders such as Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), and Alzheimer's Disease (AD), highlighting the latest gene therapy approaches for each condition. Each chapter provides a detailed introduction to the relevant field before exploring specific tools and applications. With contributions from leading experts, the book addresses the current and ongoing clinical trials, the potential challenges, and the promising advances in gene therapy for neurodegenerative disorders. It also discusses the regulatory and ethical considerations in translating research from bench to bedside. This book is an essential resource for basic science researchers in gene therapy, geneticists, biotechnologists, and clinical researchers seeking new effective treatments for neurodegenerative diseases. It equips readers with the knowledge and tools needed to advance their work and drive innovation in gene therapy.

Biomarkers for Cancer Screening, Diagnosis and Targeted Therapeutic Approaches

1st Edition
Volume 170
June 1, 2026
English
Hardback
9 7 8 0 4 4 3 4 3 2 7 2 9
eBook
9 7 8 0 4 4 3 4 3 2 7 3 6

This comprehensive volume, Biomarkers for Cancer Screening, Diagnosis and Targeted Therapeutic Approaches, provides an integrated overview of the current state and future directions of biomarker research in oncology. The book bridges fundamental molecular insights with clinical applications, emphasizing how biomarkers are transforming cancer detection, diagnosis, prognosis, and personalized treatment strategies. It brings together recent advancements in molecular diagnostics, predictive and prognostic markers, and targeted therapeutic development across a wide range of cancer types. Structured to guide both researchers and clinicians, the volume explores the classification of biomarkers, technological innovations in detection methods, and the implications of biomarker-based precision medicine in clinical decision-making. By combining interdisciplinary perspectives—from molecular biology and genetics to translational oncology—the book serves as an essential reference for oncologists, biomedical scientists, and healthcare professionals striving to improve patient outcomes through biomarker-driven cancer care.

Medical and Health Genomics of South Asia

1st Edition
May 31, 2026
Dhavendra Kumar + 1 more
English
Paperback
9 7 8 0 4 4 3 1 5 9 2 2 0
eBook
9 7 8 0 4 4 3 1 5 9 2 3 7

Medical and Health Genomics of South Asia, a new volume in the Genomic and Precision Medicine in Clinical Practice series, offers a thorough discussion of medical genomics as applied across South Asian nations, from India to Pakistan, Bangladesh, Sri Lanka, and Nepal, as well as in South Asian populations abroad. Here, global chapter authors consider genomic variation and the population heterogeneity of genetic, infectious, and lifestyle diseases in South Asia, along with successful modes of population health management for these inherited disorders and other applications of clinical genomics for improved individual health in the region.Adopting an applied approach, this book first reviews basic genomic models and population study formats, as well as the anthropological and genetic history of South Asia. The following sections examine genomic epidemiology and population health in the South Asian context; examples of genomic medicine's use in combating major health challenges in the region; genomic healthcare infrastructure; and related social, ethical, legal, and economic aspects central to impactful genomic medicine.

Non-Invasive Prenatal Screening of Rare Fetal Genetic Diseases

1st Edition
May 28, 2026
Riyaz Ahmad Rather
English
Paperback
9 7 8 0 4 4 3 2 7 6 6 0 6
eBook
9 7 8 0 4 4 3 2 7 6 6 1 3

Non-Invasive Prenatal Screening of Rare Fetal Genetic Diseases offers a comprehensive exploration of the latest advancements in non-invasive prenatal screening (NIPS) technologies and their application in detecting rare fetal genetic disorders. This book serves as an essential resource for healthcare professionals, researchers, and clinicians involved in prenatal care and genetic counseling. The main theme of the book is the exploration of NIPS methods, focusing on their application for the detection of rare fetal genetic disorders and their role in modernizing prenatal care practices. The book provides a detailed overview of the current methods in NIPS technology, the application of NIPS in detecting rare genetic disorders, and the ethical considerations involved. The book delves into advanced genomic methods such as Next-Generation Sequencing, Single-Nucleotide Polymorphism analysis, and Comparative Genomic Hybridization, highlighting their impact on the accuracy and scope of NIPS. It also covers specific genetic disorders, including Trisomy 18, Trisomy 13, Duchenne Muscular Dystrophy, Angelman Syndrome, Turner Syndrome, and Cri du Chat Syndrome, providing practical insights and case studies to illustrate real-world applications. This book addresses the need for up-to-date information on NIPS for detecting rare genetic disorders, offering a thorough exploration of emerging trends, potential challenges, and ethical considerations. Researchers will find it a valuable resource for understanding and applying NIPS protocols in their work, while clinicians will benefit from practical insights on appropriate screening methods, interpreting NIPS results, and counseling expectant parents. This book is an essential resource for researchers in obstetrics and gynecology, genetic counselors, and professionals in the biotechnology and pharmaceutical industries. It equips readers with the knowledge and tools needed to advance their work and improve prenatal care practices.

Neurogenetic Therapies

1st Edition
May 12, 2026
Ashutosh Pareek + 4 more
English
Paperback
9 7 8 0 4 4 3 4 0 5 7 4 7
eBook
9 7 8 0 4 4 3 4 0 5 7 5 4

Neurogenetic Therapies: Advancements in Treating Nervous System Disorders offers a comprehensive resource on the latest gene therapy techniques and their applications in treating neurological disorders. This authoritative guide is designed to provide students, researchers, and clinicians with in-depth knowledge of innovative gene transfer technologies and their clinical implications. The book delves into various gene therapy methods, including genomic DNA-based therapies, vector-mediated delivery, and RNA interference-based gene silencing. It explores the use of these techniques in treating conditions such as Alzheimer's disease, Parkinson's disease, spinal muscular atrophy, and Duchenne muscular dystrophy. Key topics include the molecular and genetic basis of nervous system disorders, the role of epigenetics, and the development of stem cell and genome editing therapies. With contributions from leading experts, the book also addresses regulatory and ethical considerations in gene therapy, providing a balanced perspective on the challenges and opportunities in this rapidly evolving field. Case studies and practical examples illustrate successful gene therapy treatments, offering valuable insights into translating research into clinical practice. This book is an essential resource for students, researchers, and scientists in neurogenetics, neurology, and molecular biology, as well as clinicians interested in the mechanisms and treatment of neurodegenerative diseases. It equips readers with the knowledge and tools needed to advance their work and drive innovation in neurogenetic therapies.

Nerve Growth Factor

1st Edition
May 4, 2026
Antonino Cattaneo + 1 more
English
Paperback
9 7 8 0 4 4 3 3 3 0 8 8 9
eBook
9 7 8 0 4 4 3 3 3 0 8 9 6

Nerve growth factor: From neuron development to neurology offers a complete guide to nerve growth factor (NGF) across health and disease. It provides a well-rounded discussion of NGF and the key properties, latest advances, and biomedical applications of this neuropeptide. The book begins with an introduction and historical overview of the discovery of NGF before exploring its molecular characteristics. It then covers NGF in organ function, with chapters ranging across the brain, immune system, blood vessels, heart, reproductive organs, teeth and lungs. NGF pharmacology is then considered in detail, with a focus on NGF as a therapeutic agent. The final section of the book covers NGF across disease, which includes Alzheimer’s disease, cancer, diseases of the eye, chronic pain and visceral disfunctions. Throughout the book, NGF is considered in the context of both mammalian and non-mammalian biology. Nerve growth factor: From neuron development to neurology is the latest volume in the Elsevier book series Molecular Mediators in Health and Disease, and is an ideal reference for researchers working across the fields of cell biology, molecular biology, pharmacology and other biomedical areas.

Vector Bornes Diseases

1st Edition
Volume 58
May 1, 2026
English
Hardback
9 7 8 0 4 4 3 1 3 7 2 7 3
eBook
9 7 8 0 4 4 3 1 3 7 2 8 0

Methods in Microbiology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Chromatin Signaling and Diseases

2nd Edition
May 1, 2026
Olivier Binda + 2 more
English
Paperback
9 7 8 0 4 4 3 1 9 0 0 1 8
eBook
9 7 8 0 4 4 3 1 9 0 0 2 5

Chromatin Signaling and Diseases, Second Edition, a volume in the Translational Epigenetics series, covers the molecular mechanisms that regulate gene expression, which governs embryonic development, growth, and human pathologies associated with aging, such as cancer. Although human genome sequencing continues to improve, molecular mechanisms regulating gene expression remain largely misunderstood. The impact of gene expression defects associated with malfunctioning chromatin signaling are considered in this update. In addition, this new edition has addresses developments in the field, from phase separation of membrane-less organelles and local segregation of factors to chromatinization of naked foreign DNA and cancer evolution as regulated by chromatin signaling.Chromatin signaling proposes that small protein domains recognize chemical modifications on the genome scaffolding histone proteins, facilitating the nucleation of enzymatic complexes at specific loci that then open up or shut down the access to genetic information, thereby regulating gene expression. The addition and removal of chemical modifications on histones, as well as the proteins that specifically recognize these are also considered.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Books in Molecular biology cellular biology and genetics